Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss

Sudden Loss of Hearing Clinical Trial

Official title: Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss

Status Recruiting

Clinical Trial Summary

sudden sensorineural hearing loss:

• idiopathic in most cases

• 5-20/100,000 new cases annually in the U.S

• no establishes pathogenesis

• treated with oral steroids in most cases

• ~50% improvement in hearing levels

• bed rest - acceptable treatment, not well investigated

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Deafness
• Hearing Loss
• Hearing Loss, Sensorineural
• Hearing Loss, Sudden
• Sudden Loss of Hearing

• NCT number: NCT00416143
• Study type: Interventional
• Source: Sheba Medical Center
• Contact: Eldar Carmel, MD
• Phone: 972-3-5302442
• Email: eldarca@sheba.health.gov.il
• Status: Recruiting
• Phase: Phase 2/Phase 3
• Start date: June 2006
• Completion date: December 2008